- Home
- KTTA vs ADIL Comparison
KTTA vs ADIL Comparison
Compare KTTA & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- ADIL
- Stock Information
- Founded
- KTTA 2020
- ADIL 2010
- Country
- KTTA United States
- ADIL United States
- Employees
- KTTA N/A
- ADIL N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- KTTA Health Care
- ADIL Health Care
- Exchange
- KTTA Nasdaq
- ADIL Nasdaq
- Market Cap
- KTTA 5.1M
- ADIL 6.0M
- IPO Year
- KTTA 2021
- ADIL 2018
- Fundamental
- Price
- KTTA $0.80
- ADIL $0.35
- Analyst Decision
- KTTA
- ADIL Strong Buy
- Analyst Count
- KTTA 0
- ADIL 1
- Target Price
- KTTA N/A
- ADIL $8.00
- AVG Volume (30 Days)
- KTTA 171.7K
- ADIL 619.5K
- Earning Date
- KTTA 08-14-2025
- ADIL 08-13-2025
- Dividend Yield
- KTTA N/A
- ADIL N/A
- EPS Growth
- KTTA N/A
- ADIL N/A
- EPS
- KTTA N/A
- ADIL N/A
- Revenue
- KTTA N/A
- ADIL N/A
- Revenue This Year
- KTTA N/A
- ADIL N/A
- Revenue Next Year
- KTTA N/A
- ADIL N/A
- P/E Ratio
- KTTA N/A
- ADIL N/A
- Revenue Growth
- KTTA N/A
- ADIL N/A
- 52 Week Low
- KTTA $0.65
- ADIL $0.22
- 52 Week High
- KTTA $7.50
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- KTTA 55.44
- ADIL 37.39
- Support Level
- KTTA $0.75
- ADIL $0.36
- Resistance Level
- KTTA $0.91
- ADIL $0.40
- Average True Range (ATR)
- KTTA 0.06
- ADIL 0.02
- MACD
- KTTA 0.02
- ADIL -0.00
- Stochastic Oscillator
- KTTA 52.10
- ADIL 7.69
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.